Tscan Therapeutics Inc (TCRX) — Defensive Interval Ratio
Tscan Therapeutics Inc (TCRX) has a Defensive Interval Ratio of 0 days as of December 2025. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $51.22K/day. Check how tangible is Tscan Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Tscan Therapeutics Inc Defensive Interval Ratio (2022–2025)
This chart shows how Tscan Therapeutics Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. Also explore TCRX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Tscan Therapeutics Inc (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Tscan Therapeutics Inc from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Tscan Therapeutics Inc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 0 days | $0.00 | $51.22K/day | $- | $0.00 | ▼ -1131 days |
| 2024 | 1131 days | $111.42 Million | $98.51K/day | $- | $111.42 Million | ▲ +413 days |
| 2023 | 718 days | $58.69 Million | $81.70K/day | $- | $58.69 Million | ▲ +718 days |
| 2022 | 0 days | $0.00 | $47.41K/day | $- | $0.00 | — |